Bottom growth, also known as genital growth, refers to the development of the external genitalia in individuals assigned female at birth (AFAB) who are taking testosterone hormone therapy. Testosterone is a hormone that promotes masculinization, and one of its effects is the development of male-like genitalia in transmasculine individuals.
Bottom growth typically starts within a few weeks to a few months of starting testosterone therapy. A significant increase in clitoral size is observed, which can range from mild enlargement to reaching a size similar to an average cisgender male's penis. The extent of growth varies among individuals, and it is important to note that everybody's response to hormones is different.
The growth is primarily due to an increase in blood flow and increased tissue formation in the clitoral area. Additionally, the clitoris can become more sensitive and may respond differently to sexual sensation. Some individuals report increased pleasure and easier orgasm after bottom growth.
It is important to mention that bottom growth does not include the development of testicles or the ability to produce sperm. Testosterone does not change the internal reproductive organs, and individuals interested in fertility preservation may need to consider other options before undergoing hormone therapy.
Trans individuals considering hormone therapy should consult with a medical professional experienced in transgender healthcare to discuss the potential effects, risks, and expectations associated with testosterone therapy, including bottom growth.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page